EUVIMEDEUVIMED entdecken
Open Access

A 5‐Azetidinyl BODIPY–Olaparib Conjugate for PARP‐Targeted Nuclear and Orthotopic Oral Tumor Imaging

Kaixiang Yan, Hengkai Qi, Xiaochun Dong iD, Weili Zhao iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Kaixiang Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Fudan University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Boron Compounds, Fluorescent Dyes, Piperazines, Mouth Neoplasms. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poly(ADP‐ribose) polymerase (PARP) is a clinically validated therapeutic target and an attractive biomarker for fluorescence‐guided tumor imaging. However, the nuclear localization of PARP imposes a stringent requirement on probe design, as fluorophore installation must not compromise nuclear entry of the targeting ligand. Herein, we report a focused series of 5‐azetidinyl BODIPY–olaparib conjugates as PARP‐targeted fluorescent probes. By attaching olaparib‐derived ligands to the 5‐position of the BODIPY core through flexible linkers, we sought to preserve conformational flexibility while introducing a donor–acceptor fluorophore with an enlarged Stokes shift. Among the synthesized probes, 1a exhibited the most favorable cellular imaging performance, showing efficient nuclear localization in PARP‐overexpressing U87 and Cal27 cells. Competitive blocking with olaparib and comparison with HEK293 cells supported PARP‐dependent imaging. In Cal27 xenograft and orthotopic oral tumor models, 1a showed rapid tumor accumulation and clear tumor visualization. It provides a wider range of probe options for intraoperative tracking of oral tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron CompoundsFluorescent DyesPiperazinesMouth NeoplasmsPoly(ADP-ribose) PolymerasesPhthalazinesPoly(ADP-ribose) Polymerase InhibitorsHumansAnimalsMiceOptical ImagingCell Line, TumorMolecular StructureMice, NudeCell Nucleus

Stichwörter der Autor:innen

BODIPYPARPfluorescent probenuclear imagingoral squamous cell carcinoma

Substanzen

Boron CompoundsFluorescent DyesPiperazinesPoly(ADP-ribose) PolymerasesPhthalazines4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneolaparibPoly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Fudan University, Shanghai, P. R. China.

ORCID-Profile: Xiaochun Dong, Weili Zhao

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yan, K., Qi, H., Dong, X., & Zhao, W. (2026). A 5‐Azetidinyl BODIPY–Olaparib Conjugate for PARP‐Targeted Nuclear and Orthotopic Oral Tumor Imaging. ChemMedChem. https://doi.org/10.1002/cmdc.70450

Vancouver

Yan K, Qi H, Dong X, Zhao W. A 5‐Azetidinyl BODIPY–Olaparib Conjugate for PARP‐Targeted Nuclear and Orthotopic Oral Tumor Imaging. ChemMedChem. 2026. doi:10.1002/cmdc.70450

BibTeX
@article{Yan2026,
  author = {Yan, Kaixiang and Qi, Hengkai and Dong, Xiaochun and Zhao, Weili},
  title = {A 5‐Azetidinyl BODIPY–Olaparib Conjugate for PARP‐Targeted Nuclear and Orthotopic Oral Tumor Imaging},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70450}
}
Kostenlos starten →